YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
6.57
-0.55 (-7.76%)
At close: Apr 7, 2026, 4:00 PM EDT
6.98
+0.41 (6.24%)
After-hours: Apr 7, 2026, 4:00 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $462 million as of April 7, 2026. Its market cap has increased by 902.06% in one year.
Market Cap
462.00M
Enterprise Value
487.72M
1-Year Change
902.06%
Ranking
Category
Stock Price
$6.57
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $462.00M, an increase of 211.41%. That is a compound annual growth rate of 23.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 490.83M | -42.74% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 511.07M |
| 4D Molecular Therapeutics | 507.45M |
| Rigel Pharmaceuticals | 505.42M |
| Lyell Immunopharma | 502.74M |
| Contineum Therapeutics | 501.80M |
| Entrada Therapeutics | 499.68M |
| Forte Biosciences | 496.23M |
| vTv Therapeutics | 490.67M |